Andrei Floroiu
2023
In 2023, Andrei Floroiu earned a total compensation of $1.9M as Former President and Chief Executive Officer at Biota Pharmaceuticals, a 48% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $198,917 |
---|---|
Option Awards | $801,895 |
Salary | $568,333 |
Stock Awards | $286,833 |
Other | $10,866 |
Total | $1,866,844 |
Floroiu received $801.9K in option awards, accounting for 43% of the total pay in 2023.
Floroiu also received $198.9K in non-equity incentive plan, $568.3K in salary, $286.8K in stock awards and $10.9K in other compensation.
Rankings
In 2023, Andrei Floroiu's compensation ranked 582nd out of 3,006 executives tracked by ExecPay. In other words, Floroiu earned more than 80.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 582 out of 3,006 | 81st |
Division Manufacturing | 332 out of 1,650 | 80th |
Major group Chemicals And Allied Products | 230 out of 918 | 75th |
Industry group Drugs | 227 out of 881 | 74th |
Industry Biological Products, Except Diagnostic Substances | 79 out of 213 | 63rd |
Source: SEC filing on April 29, 2024.
Floroiu's colleagues
We found two more compensation records of executives who worked with Andrei Floroiu at Biota Pharmaceuticals in 2023.